Figure 2From: Plasma specific miRNAs as predictive biomarkers for diagnosis and prognosis of gliomaExpression levels miR-15b, miR-221/222, miR-181a/d/c levels in plasma of healthy controls and GBM patients. All these miRNAs are normalized to mmu-miR-295 and analyzed using 2-△△Ct method. Statistically significant differences were determined using the Mann–Whitney U test. There was no significant difference between controls and GBM patients (P > 0.05).Back to article page